Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
Although prostate biopsy is the gold standard for the diagnosis of prostate cancer, it also leads to high incidence of negative biopsies and the diagnosis of clinically low-risk prostate cancer and the subsequent overtreatment. It remains an unmet need to discover new biomarkers in order to defer th...
Main Authors: | Lie-Fu Ye, Sha He, Xiaopei Wu, Shengying Jiang, Ruo-Chen Zhang, Ze-Song Yang, Fa-Wen Chen, Dan-Ling Pan, Dong Li, Gang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2020-01-01
|
Series: | Prostate Cancer |
Online Access: | http://dx.doi.org/10.1155/2020/3964615 |
Similar Items
-
A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA
by: Igor Brikun, et al.
Published: (2018-07-01) -
Prostatic specific antigen for prostate cancer detection
by: Lucas Nogueira, et al.
Published: (2009-10-01) -
Prostate specific antigen negative prostate cancer
by: Birtle, A. J.
Published: (2005) -
Prostate-specific antigen and free prostate-specific antigen/prostate-specific antigen ratio in patients with benign prostatic hyperplasia and prostate cancer
by: Amal A. Hussein, et al.
Published: (2020-12-01) -
Gene‒Prostate-Specific-Antigen-Guided Personalized Screening for Prostate Cancer
by: Teng-Kai Yang, et al.
Published: (2019-08-01)